FDA Drug Safety Information for March 20, 2024

Mar 202024
 

Date Brand Name(s) Description Type Reason Company  3/20/2024 Nimbus Nimbus Pump System Medical Devices Recall due to a high number (3698) of customer complaints related

FDA Drug Safety Information for March 12, 2024

Mar 122024
 

Date Brand Name(s) Description Type Reason Company  3/12/2024 Par Pharmaceutical Treprostinil 20mg/20mL Injection Drugs Potential Presence of Silicone Particulate Matter Endo International, Par Pharmaceutical

FDA Novel Drug Approvals – February 2024

Mar 012024
 

Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Letybo letibotulinumtoxinA-wlbg 2/29/2024 To temporarily improve the appearance of

FDA Drug Safety Information for February 29, 2024

Feb 292024
 

Date Brand Name(s) Description Type Reason Company  2/29/2024 Megadyne Mega Soft Universal and Universal Plus Reusable Patient Return Electrodes Medical Devices Limit use to patients

FDA Drug Safety Information for February 27, 2024

Feb 272024
 

Date Brand Name(s) Description Type Reason Company  2/27/2024 Avanos Medical MIC* Gastric-Jejunal Feeding Tube Kits Medical Devices Potential Lack of Sterility Assurance Avanos Medical, Inc.

FDA Drug Safety Information for February 5, 2024

Feb 052024
 

Date Brand Name(s) Description Type Reason Company  2/5/2024 Sustain, Schwinnng Sustain and Schwinnng brand male enhancement capsules Drugs Products contain undeclared Tadalafil and Nortadalafil Today

FDA Drug Safety Information for February 2, 2024

Feb 022024
 

Date Brand Name(s) Description Type Reason Company  2/2/2024 TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid Drugs Presence of benzene Insight Pharmaceuticals

FDA Novel Drug Approvals – January 2024

Feb 012024
 

Drug Name Active Ingredient(s) Approval Date FDA-Approved Use on Approval Date Press Release Drug Trials Snapshot Zelsuvmi berdazimer 1/5/2024 To treat molluscum contagiosum Drug Trials

 Older Entries  Newer Entries